Avct share chat

We could not find any results for: Make sure your spelling is correct or try broadening your avct share chat. It looks like you aren't logged in. Click the button below to log in and view your recent history. Already a member?

Hey yeah finally could see numbers in green Thanks to you and Goldshare This is beginning to look suspiciously like a pump and dump to me. Lots of hype on Twitter pushing the price up, then it crashes, then repeats. Only inaccuracy is the talk of phase 3, which Ceo has stated unlikely to be required as its using a well known and understood drug. Imo phase 1a was the riskiest part, knowing that dox successfully cleaved and is present at much higher concentrations than in the blood stream.

Avct share chat

They updated the market this morning that their technology maybe a potential therapy for blocking Covid Would like to see Avacta added. If you look up Myles McNulty on Twitter, the guy is an absolute guru when it comes to this company. Long story short, if their test results get validated in a clinical setting should find out about that in the next weeks then its going to go through the roof. Still a great entry point. Long term, their revolutionary cancer treatments are the real play but the Covid test is the thing most people are focused on. I opened a small position this month. Of course, if the Covid test hits the skids or gets further delayed there will likely be a sharp contraction but I think its becoming clearer by the day that mass testing is going to be here for a good while yet and it is better to be late to the party with potentially the most reliable rapid test in the world than rush something out that only half works. Thank you Alex! Expecting mega price action on Monday and huge announcements from the prime minister down. Got in late with this stock at 1. Does anyone know why this is slipping? The performance of all rapid antigen tests has come under recent scrutiny in light of the large number of mutations in the Omicron variant of the SARS-CoV-2 virus and the US Food and Drug Administration, as well as other sources, has indicated that antigen tests generally will detect the Omicron variant but may have reduced sensitivity. We have, of course, been unable to market the product in the UK since October , as the product continues to await approval under the new CTDA regulatory process. This mutant is already the dominant SARS-CoV-2 variant in many countries and may soon be the dominant variant globally.

Chat Pages: Older. Sign in. Important Documents There are no documents available for this stock.

This means our website may not look and work as you would expect. Read more about browsers and how to update them here. It also means that information relating to the fundraising is limited to the Company announcement. Due to the nature of the fundraising, applications can close at any time and without prior warning. Option 1 — Do Nothing.

GBX Key events shows relevant news articles on days with large price movements. Greatland Gold plc. GGP 3. Argo Blockchain PLC. ARB 3. Eurasia Mining plc. EUA 3. I3 Energy PLC.

Avct share chat

We could not find any results for: Make sure your spelling is correct or try broadening your search. It looks like you aren't logged in. Click the button below to log in and view your recent history. Already a member? Sign in. More Brokers. It looks like you are not logged in.

Net worth of steven furtick

Trade low : Most likely coincide with mainstream media news coverage. Market capitalisation. Excellent write up with background here for all new investors. Oncologists to boot!! Well what about the long-term investors that were sold a pup. Thanks longshanks. FTSE 7, This may be delayed in the event the company does not deliver your shares to us by this time. EfrendoX Efren 19 February 6. Option 1 — Do Nothing.

.

Any instruction to participate in the Retail Offer must be received by 9am on Monday 04 March. Read Full Thread Reply. Trade high : A terminal patient with STS is showing a reduction in tumour volume. Dow Jones 38, Wealth Shortlist fund Our analysts have selected this fund for the Wealth Shortlist. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website. Oncologists to boot!! In fact it is a disgrace saying that shareholders should only consider Avacta as a new company! Performance figures are based on the previous close price. Bounce time, little shake earlier failed and offer now is up to Brent Oil Jimbo Jimbo 19 September